CES Award 2025

We are pioneering single-molecule techniques to transform drug development. Our NanoLoom platform provides real-time, high-resolution insights into protein-DNA interactions, advancing research in antivirals, antibiotics, and genome-related diseases. 1NA has been recognized as a CES 2025 Innovation Awards Honoree for our groundbreaking NanoLoom technology.

2025 Honoree

This innovative platform is poised to meet pharmaceutical industry demands, accelerating drug development, repurposing, and combination therapy identification.

Learn more

Meet us
in Vegas

Plan a meeting

Connect with our founders in Las Vegas to dicover our platform and explore investment opportunities.

NanoLoom is the first single-molecule platform designed for large-scale drug screening. By aligning thousands of DNA molecules within a single view, it enables researchers to visualize protein dynamics in real time, analyze drug efficacy with precision, and accelerate the identification of drug candidates.

Become a partner

After securing pre-seed funding and establishing academic partnerships with industry collaborators, we are now seeking pharmaceutical partners to validate NanoLoom’s technology in real-world drug development settings. Together, we can accelerate antiviral and antibiotic research and unlock new therapeutic opportunities.